慢性充血性心力衰竭患者的胰岛素抵抗及药物干预的临床观察(PDF)
《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]
- 期数:
- 2000年第2期
- 页码:
- 105-107
- 栏目:
- 论著
- 出版日期:
- 2000-03-25
文章信息/Info
- Title:
- Clinical investigations of insulin resistance in patients with chronic congestive heart failure and drugs intervention
- Author(s):
- LI Min-yun 1; YANG Xin-guo2; ZHANG Ning-zi2; HOU Ying-long2; ZHENG Qiang-sun2; CHU Xi-qin2
- 1Department of Cardiology, Jiangxi Provincial Corps Hospital of Chinese People′s Armed Police Force,Nanchang 330001, Jiangxi, China 2Department of Cardiology,Tangdu Hospital, Fourth Military Medical University, Shaanxi, China
- Keywords:
- heart failure; congestive; insulin resistance; fosinopril; indapamide
- 分类号:
- R541.61
- DOI:
- -
- 文献标识码:
- A
- 摘要:
- 为观察慢性充血性心力衰竭 (CHF)患者的血胰岛素和糖代谢变化 ,进一步证实 CHF与胰岛素抵抗 (IR)的关系 ,并探讨福辛普利和吲哒帕胺对 CHF患者胰岛素敏感性的影响。对 CHF患者 4 0例检测福辛普利 (5mg～ 1 0mg,1次 / d)或吲哒帕胺 (2 .5mg,1次 / d)治疗前和治疗 4周后及 2 5例健康对照者空腹血糖 (FPG)、空腹血清胰岛素 (FINS)和空腹血清 C肽 (CP)水平 ,并计算出 FPG/ FINS比值、IAI值 [IAI=-ln(FPG× FINS) ]作为机体胰岛素敏感性评价指标 ,分别比较 CHF组与对照组、CHF组患者治疗前后的胰岛素敏感性变化。结果 :CHF组患者的胰岛素敏感性明显低于对照组 ,FINS水平高于对照组。治疗 4周后 ,福辛普利组 CHF患者的胰岛素敏感性显著增加 ,而吲哒帕胺组患者胰岛素敏感性无显著变化。提示: ①CHF 患者存在继发性IR 和?或高胰岛素血症, IR 和高胰岛素血症可能与CHF 患者心功能进一步恶化有关。②福辛普利有改善CHF 患者IR 的作用。
- Abstract:
- To observe the changes in insulin sensitivity in patients with chronic congestive heart failure (CHF), assess the relation between CHF and insulin resistance (IR), and study the effects of fosinopril and indapamide on insulin sensitivity,fasting plasma glucose (FPG),fasting serum insulin (FINS) and fasting serum c peptide (CP) were measured in 40 patients with CHF before and after fosinopril (5~10 mg,q.d) or indapamide (2.5 mg,q.d) treatment for 4 weeks and in 25 healthy control subjects FPG/FINS and Ln1/FPG×FINS( IA I) were counted in each case. Insulin sensitivity was estimated by FPG/FIN S and IAI. The result s were compared with those of the control subjects. It was shown that the patients with CHF had lower insulin sensitivity and higher FINS levels. At the end of the 4th week after the treatment, insulin sensitivity was increased in fosinopril group but showed no change in the indapamide group. These result s suggested that the patients with CHF suffered the secondary IR and/or hyperinsulinaemia. IR and hyperinsulinaemia may be responsible for the progressive deterioration of heart function and fosinopril can improve IR in patients with CHF.
参考文献/References
［1］ Polonsky KS, Rubenstenin AH. C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitation[J ]. Diabetes, 1984, 33: 486.
[2] Swan JW, Anker SD, Walton C, et al. Insulin resistance in chronic heart failure: relation to severity and etio logy of heart failure[J ]. J Am Coll Cardiol, 1997, 30: 527.
[3] 袁文娟, 杨欣国, 杜日映. 慢性充血性心力衰竭患者胰岛素抵抗的临床观察[J]. 临床心血管病杂志, 1997, 13 (6) : 334.
[4] Feldman RD, Bierbrier GS. Insulin mediated vasodilation: impairment with increased blood pressure and body mass [J ]. Lancet, 1993, 342: 707.
[5] DeF ronzo RA. The effect of insulin on renal sodium metobolism: a review with clinical implications [ J ]. Diabetologia, 1981, 21: 165.
[6] Mc Nulty PH, Louard RJ , Deckelbaum LI, et a l. Hyperinsulinaemiain hibits myocardial protein degradation in patients with cardiovascular disease and insulin resistance[J]. Circulation, 1995, 92: 2151.
[7] Kap lan NM. Effects of antihypertensive therapy on insulin resistance[J ]. H yp ertension, 1992, 19 ( supp l 1) : 1116
[8] 苗志林, 佟铭, 刘际清, 等. 高血压病患者及其正常血压子女胰岛素分泌功能及其药物干预的观察[J ]. 中华心血管病杂志, 1993, 21 (5) : 279.
[9] Raggi U , Palumbo P, Mo ro B, et al. Indapamide in the treatment of hypertension in non-insulin-dependent diabetes [J ]. Hypertension, 1985, 7 (6p t2) : 157.
[10] HaenniA , Berglund L , Reneland R, et al. The alterations in insulin sensitivity during angiotensin converting enzyme inhibitor treatment are related to changes in calcium/magnesium blalance[J ]. Am J Hypertens, 1997, 10 (2) : 145.
备注/Memo
- 备注/Memo:
- 收稿日期：1999-03-08.
常用功能
统计/Statistics
- 摘要浏览/Viewed1188
- 全文下载/Downloads738
- 评论/Comments
